Knocking down PKD using specific siRNA or exposure to the ERK inhibitor U0126 increased the sensitivity of HCT116 cells to the physiological anti-CRC agent sodium butyrate (NaBt) [51,52]. This evidence concerns the gene PRKD1 and colorectal carcinoma.